Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Daniela Deriu has worked on the following 4 EPO patent applications which have been published in the last five years:

EP11746252

ANTIBODIES FOR EPIDERMAL GROWTH FACTOR RECEPTOR 3 (HER3)

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/32
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
PATENT GRANTED
EP11718982

COMPOSITIONS AND METHODS OF USE FOR THERAPEUTIC LOW DENSITY LIPOPROTEIN -RELATED PROTEIN 6 (LRP6) ANTIBODIES

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/28, C07K 16/46, C12N 15/113
Applicant:
Novartis AG
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Daniela Deriu, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP11723308

COMPOSITIONS AND METHODS OF USE FOR THERAPEUTIC LOW DENSITY LIPOPROTEIN - RELATED PROTEIN 6 (LRP6) MULTIVALENT ANTIBODIES

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/28, C07K 16/46, C12N 15/113
Applicant:
Novartis AG
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Daniela Deriu, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11785007

METHODS OF TREATING FGF21-ASSOCIATED DISORDERS

IPC classification:
C07K 14/50
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS

Please Sign in to use this feature